The DOI matches its Crossref record; 124 of the 130 references it cites were found in a registry or an index.
A review of opioid dependence treatment: Pharmacological and psychosocial interventions to treat opioid addiction
Abstract
Opioid dependence is a problem of national concern, especially with dramatically increased rates of abuse and dependence of prescription opioids. The current article provides an up-to-date review of the literature on opioid dependence treatment, with a focus on conclusions drawn by experts in the field (e.g., Cochrane reviews and meta-analyses) and methodologically rigorous studies (e.g., randomized controlled trials). We describe the major classes of drug treatments available, including opioid agonist (e.g., methadone, buprenorphine, LAAM), antagonist (e.g., naltrexone) and non-opioid pharmacotherapies (e.g., alpha2 adrenergic agonists). These treatments are discussed in the context of detoxification and long term treatment options such as abstinence-based and maintenance strategies. We review the state of the literature as to prevention of opioid overdose and discuss the widespread problem of comorbidity among opioid-dependent populations. We also focus prominently on evidence for inclusion of psychosocial approaches in treatment regimens, either as stand-alone or in conjunction with psychopharmacological options.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is a dearth of research investigating the efficacy of psychosocial treatments in reducing opioid use among people living with chronic pain.42,43”
Citations
Cites
2 retracted
Psychosocial treatment for opiate abuse and dependence
Mayet, S., Farrell, M., Ferri, M., Amato, L., & Davoli, M. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004330.pub2 · Cited by 106
RetractedPsychosocial treatment for opiate abuse and dependence
Mayet, S., Farrell, M., Ferri, M., Davoli, M., & Amato, L. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004330 · Cited by 12
RetractedMonitoring the Future: National Results on Adolescent Drug Use: Overview of Key Findings
Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2003) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1037/e560352009-001 · Cited by 6,930
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors
Washton, A. M. (1986) · Journal of Studies on Alcohol · doi:10.15288/jsa.1986.47.260 · Cited by 2,531
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C. L., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,312
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209.pub2 · Cited by 1,654
Volume, I. I. (2017) · Institute for Social Research eBooks · doi:10.3998/2027.42/139710 · Cited by 1,369
A Meta-Analytic Review of Psychosocial Interventions for Substance Use Disorders
Dutra, L., Stathopoulou, G., Basden, S. L., Leyro, T. M., Powers, M. B., & Otto, M. W. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111851 · Cited by 1,287
Results from the 2003 National Survey on Drug Use and Health: National Findings
(2004) · PsycEXTRA Dataset · doi:10.1037/e400442005-001 · Cited by 1,245
Dole, V. P. (1965) · JAMA · doi:10.1001/jama.1965.03090080008002 · Cited by 1,240
Addictive Drugs and Brain Stimulation Reward
Wise, R. A. (1996) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.19.030196.001535 · Cited by 792
Organization of endogenous opiate and nonopiate pain control systems
Watkins, L. R., & Mayer, D. J. (1982) · Science · doi:10.1126/science.6281891 · Cited by 791
Psychiatric and Substance Use Comorbidity Among Treatment-Seeking Opioid Abusers
Brooner, R. K. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830130077015 · Cited by 745
Connock, M., Juarez-Garcia, A., Jowett, S., Frew, E., Liu, Z., Taylor, R., Fry-Smith, A., Day, E., Lintzeris, N., Roberts, T. E., et al. (2007) · Health Technology Assessment · doi:10.3310/hta11090 · Cited by 610
Amato, L., Davoli, M., A.Perucci, C., Ferri, M., Faggiano, F., & P. Mattick, R. (2005) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2005.02.007 · Cited by 567
Oral naltrexone maintenance treatment for opioid dependence
Minozzi, S., Amato, L., Vecchi, S., Davoli, M., Kirchmayer, U., & Verster, A. D. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001333.pub4 · Cited by 436
Addiction to opioids in chronic pain patients: A literature review
Højsted, J., & Sjøgren, P. (2007) · European Journal of Pain · doi:10.1016/j.ejpain.2006.08.004 · Cited by 424
Role of maintenance treatment in opioid dependence
Ward, J., Hall, W., & Mattick, R. P. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05356-2 · Cited by 419
Methadone maintenance at different dosages for opioid dependence
Faggiano, F., Vigna‐Taglianti, F., Versino, E., & Lemma, P. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002208 · Cited by 414
Fortnightly Review: Methadone maintenance treatment in opiate dependence: a review
Farrell, M., Ward, J., Mattick, R. P., Hall, W., Stimson, G. V., Jarlais, D. D., Gossop, M., & Strang, J. (1994) · BMJ · doi:10.1136/bmj.309.6960.997 · Cited by 393
Heroin overdose: causes and consequences
Warner‐Smith, M., Darke, S. G., Lynskey, M. T., & Hall, W. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.96811135.x · Cited by 382
Amato, L., Minozzi, S., Davoli, M., & Vecchi, S. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004147.pub4 · Cited by 379
Diacetylmorphine versus Methadone for the Treatment of Opioid Addiction
Oviedo‐Joekes, E., Brissette, S., Marsh, D. C., Lauzon, P., Guh, D. P., Anis, A. H., & Schechter, M. T. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810635 · Cited by 371
Comer, S. D., Sullivan, M. A., Yu, E., Rothenberg, J. L., Kleber, H. D., Kampman, K., Dackis, C., & O’Brien, C. P. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.210 · Cited by 348
There and Back Again: A Tale of Norepinephrine and Drug Addiction
Weinshenker, D., & Schroeder, J. P. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301263 · Cited by 347
Heroin Overdose: Research and Evidence-Based Intervention
Darke, S. G. (2003) · Journal of Heredity · doi:10.1093/jurban/jtg022 · Cited by 332
Gonzalez, J. P., & Brogden, R. N. (1988) · Drugs · doi:10.2165/00003495-198835030-00002 · Cited by 315
Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta‐analytical review
Johansson, B. A., Berglund, M., & Lindgren, A. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01369.x · Cited by 305
Buprenorphine for the management of opioid withdrawal
Gowing, L., Ali, R., & White, J. M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002025.pub4 · Cited by 297
Contingency management in outpatient methadone treatment: a meta-analysis
Griffith, J. D., Rowan‐Szal, G. A., Roark, R. R., & Simpson, D. D. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00068-x · Cited by 291
Gossop, M., Stewart, D., Browne, N., & Marsden, J. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00227.x · Cited by 284
Noble, M., Tregear, S., Treadwell, J. R., & Schoelles, K. M. (2008) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2007.03.015 · Cited by 274
Efficacy of antidepressants in substance use disorders with and without comorbid depression
Torrens, M., Fonseca, F., Mateu-Codina, G., & Farré, M. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.09.004 · Cited by 272
Alpha2-adrenergic agonists for the management of opioid withdrawal
Gowing, L., Farrell, M., Ali, R. L., & White, J. M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002024.pub5 · Cited by 272
The economic costs of heroin addiction in the United States
Mark, T. L. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00162-9 · Cited by 271
Heroin-assisted treatment for opioid dependence
Haasen, C., Verthein, U., Degkwitz, P., Berger, J., Krausz, M. R., & Naber, D. (2007) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.106.026112 · Cited by 264
QT-Interval Effects of Methadone, Levomethadyl, and Buprenorphine in a Randomized Trial
Wedam, E. F. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.22.2469 · Cited by 258
Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs
Cunha‐Oliveira, T., Rego, A. C., & Oliveira, C. R. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.03.002 · Cited by 243
Amato, L., Minozzi, S., Davoli, M., & Vecchi, S. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005031.pub4 · Cited by 235
Methadone at tapered doses for the management of opioid withdrawal
Amato, L., Davoli, M., Minozzi, S., Ferroni, E., Ali, R. L., & Ferri, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003409.pub4 · Cited by 229
Smith, R. J., & Aston-Jones, G. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0191-3 · Cited by 206
Substitution treatment of injecting opioid users for prevention of HIV infection
Gowing, L., Farrell, M., Bornemann, R., & Ali, R. L. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004145.pub2 · Cited by 204
Polydrug dependence and psychiatric comorbidity among heroin injectors
Darke, S. G., & Ross, J. E. (1997) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(97)00117-8 · Cited by 198
McCabe, S. E., Cranford, J. A., & West, B. T. (2008) · Addictive Behaviors · doi:10.1016/j.addbeh.2008.06.005 · Cited by 197
Strang, J., Manning, V., Mayet, S., Best, D. W., Titherington, E., Santana, L., Offor, E., & Semmler, C. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02314.x · Cited by 197
Are detoxification programmes effective?
Mattick, R. P., & Hall, W. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90215-9 · Cited by 196
Wagner, K. D., Valente, T. W., Casanova, M., Partovi, S. M., Mendenhall, B. M., Hundley, J. H., Gonzalez, M., & Unger, J. B. (2009) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2009.01.003 · Cited by 192
Green, T. C., Heimer, R. R., & Grau, L. E. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02182.x · Cited by 192
Altered methadone pharmacokinetics in methadone-maintained pregnant women.
Pond, S. M., Kreek, M. J., Tong, T. G., Raghunath, J., & Benowitz, N. L. (1985) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21130-2 · Cited by 189
The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients
Cacciola, J. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00148-4 · Cited by 182
Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis
Farré, M., Mas, A., Torrens, M., Moreno, V. R., & Camı́, J. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00171-5 · Cited by 180
Evidence-Based Treatment of Opioid-Dependent Patients
van den Brink, W., & Haasen, C. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605101003 · Cited by 147
Take‐home naloxone to reduce heroin death
Baca, C. T., & Grant, K. J. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01259.x · Cited by 137
Stress and drug-cue-induced craving in opioid-dependent individuals in naltrexone treatment
Hyman, S. M., Fox, H., Hong, K.-I. A., Doebrick, C., & Sinha, R. (2007) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.15.2.134 · Cited by 133
Assessment and Treatment of Comorbid Psychiatric Disorders in Opioid-Dependent Patients
Strain, E. C. (2002) · Clinical Journal of Pain · doi:10.1097/00002508-200207001-00003 · Cited by 132
Green, T. C., Serrano, J. M. G., Licari, A., Budman, S. H., & Butler, S. F. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.03.014 · Cited by 127
Julien, R. M. (1997) · Medical Entomology and Zoology · Cited by 120
Prescription Naloxone: A Novel Approach to Heroin Overdose Prevention
Sporer, K. A., & Kral, A. H. (2006) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2006.05.025 · Cited by 117
Behavioral family counseling and naltrexone for male opioid-dependent patients.
Fals-Stewart, W., & O'Farrell, T. J. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.3.432 · Cited by 116
Substitution treatment of injecting opioid users for prevention of HIV infection
Gowing, L., Farrell, M., Bornemann, R., Sullivan, L. E., & Ali, R. L. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004145.pub3 · Cited by 116
Sustained-Release Naltrexone For Opioid Dependence
Lobmaier, P. P. K., Kornør, H., Kunøe, N., & Bjørndal, A. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006140.pub2 · Cited by 109
Alpha2 adrenergic agonists for the management of opioid withdrawal
Gowing, L., Farrell, M., Ali, R. L., & White, J. M. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002024.pub2 · Cited by 107
Naltrexone and buprenorphine combination in the treatment of opioid dependence
Gerra, G., Fantoma, A., & Zaimovic, A. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106060835 · Cited by 106
Avants, S. K., Margolin, A., Usubiaga, M. H., & Doebrick, C. (2004) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(03)00159-4 · Cited by 106
Oral naltrexone maintenance treatment for opioid dependence
Minozzi, S., Amato, L., Vecchi, S., Davoli, M., Kirchmayer, U., & Verster, A. D. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001333.pub2 · Cited by 106
Schottenfeld, R. S., Chawarski, M. C., & Mazlan, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60954-x · Cited by 99
Consensus statement on office-based treatment of opioid dependence using buprenorphine
Fiellin, D. A., Kleber, H. D., Trumble, J. G., McLellan, A. T., & Kosten, T. R. (2004) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2004.06.005 · Cited by 96
LAAM maintenance vs methadone maintenance for heroin dependence
Clark, N. C., Lintzeris, N., Gijsbers, A. J., Whelan, G., Dunlop, A. J., Ritter, A. J., & Ling, W. W. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002210 · Cited by 93
Krupitsky, E. M., Zvartau, E. E., Masalov, D. V., Tsoy, M. V., Burakov, A. M., Egorova, V. Y., Didenko, T. Y., Romanova, T. N., Ivanova, E. B., Bespalov, A. Y., et al. (2006) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2006.05.005 · Cited by 93
Subramaniam, G., & Stitzer, M. L. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.10.015 · Cited by 93
Behavioral Therapy to Augment Oral Naltrexone for Opioid Dependence: A Ceiling on Effectiveness?
Nunes, E. V., Rothenberg, J. L., Sullivan, M. A., Carpenter, K. M., & Kleber, H. D. (2006) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990600918973 · Cited by 92
Psychiatric Comorbidity: Prevalence in Methadone Maintenance Treatment
Milby, J. B., Sims, M., Khuder, S., Schumacher, J. E., Huggins, N., McLellan, A. T., WOODY, G. E., & Haas, N. (1996) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999609001647 · Cited by 89
Integrating psychotherapy and pharmacotherapy to improve drug abuse outcomes
Carroll, K. M. (1997) · Addictive Behaviors · doi:10.1016/s0306-4603(96)00038-x · Cited by 85
Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal
Gowing, L., Ali, R. L., & White, J. M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002022.pub3 · Cited by 84
Differential activation of G‐proteins byμ‐opioid receptor agonists
Saidak, Z., Blake-Palmer, K. G., Hay, D. L., Northup, J. K., & Glass, M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706661 · Cited by 81
Shippenberg, T. S., Chefer, V. I., & Thompson, A. C. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.09.009 · Cited by 80
Effectiveness of interventions on opiate withdrawal treatment: an overview of systematic reviews
Amato, L., Davoli, M., Ferri, M., Gowing, L., & Perucci, C. A. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2003.11.002 · Cited by 80
Opioid antagonists with minimal sedation for opioid withdrawal
Gowing, L., Ali, R. L., & White, J. M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002021.pub4 · Cited by 78
Helm, S. (2008) · Pain Physician · doi:10.36076/ppj.2008/11/225 · Cited by 78
Methadone at tapered doses for the management of opioid withdrawal
Amato, L., Davoli, M., Minozzi, S., Ali, R. L., & Ferri, M. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003409.pub3 · Cited by 77
Banta‐Green, C. J., Maynard, C. C., Koepsell, T. D., Wells, E. A., & Donovan, D. M. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02538.x · Cited by 75
Mendelson, J. E., Flower, K., Pletcher, M. J., & Galloway, G. P. (2008) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0013637 · Cited by 74
Optimizing Long-Term Response to Methadone Maintenance Treatment
Maxwell, S., & Shinderman, M. S. (2002) · Journal of Addictive Diseases · doi:10.1300/j069v21n03_01 · Cited by 71
Depression of Morphine-seeking Behaviour by Dopamine Inhibition
Schwartz, A. S., & Marchok, P. L. (1974) · Nature · doi:10.1038/248257a0 · Cited by 68
The Treatment of Opioid Dependence
Galanter, M. S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.9.1650 · Cited by 66
Pharmacotherapy of Dual Substance Abuse and Dependence
Kenna, G. A., Nielsen, D. M., Mello, P., Schiesl, A., & Swift, R. M. (2007) · CNS Drugs · doi:10.2165/00023210-200721030-00003 · Cited by 65
Helm, S., Trescot, A. M., Colson, J. D., Sehgal, N., & Silverman, S. M. (2008) · PubMed · Cited by 64
Heroin maintenance for chronic heroin dependents
Ferri, M., Davoli, M., & Perucci, C. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003410 · Cited by 63
Ziedonis, D. M., Amass, L., Steinberg, M. L., WOODY, G. E., Krejci, J. A., Annon, J. J., Cohen, A. J., Waite-O’Brien, N., Stine, S. M., McCarty, D. W., et al. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.06.016 · Cited by 63
Amato, L., Minozzi, S., Davoli, M., Vecchi, S., Ferri, M., & Mayet, S. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005031.pub2 · Cited by 62
Castells, X., Kosten, T., Capellà, D., Vidal, X., Colom, J., & Casas, M. (2009) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990903108215 · Cited by 60
Psychopathology and HIV risk behaviors among injection drug users in and out of treatment
Dinwiddie, S. H., Cottler, L. B., Compton, W. M., & Abdallah, A. B. (1996) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(96)01290-2 · Cited by 59
Blood naltrexone levels over time following naltrexone implant
Ngo, H., Arnold-Reed, D. E., Hansson, R. C., Tait, R. J., & Hulse, G. K. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.06.007 · Cited by 58
Methods of Detoxification and Their Role in Treating Patients With Opioid Dependence
O’Connor, P. G. (2005) · JAMA · doi:10.1001/jama.294.8.961 · Cited by 58
Amato, L., Minozzi, S., Davoli, M., Vecchi, S., Ferri, M., & Mayet, S. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004147.pub3 · Cited by 57
Slow tapering from methadone maintenance in a program encouraging indefinite maintenance
Calsyn, D. A., Malcy, J. A., & Saxon, A. J. (2006) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2005.11.007 · Cited by 55
Kadden, R., Kranzler, H., & Rounsaville, B. (1995) · American Journal on Addictions · doi:10.1111/j.1521-0391.1995.tb00441.x · Cited by 54
Management of relapse in naltrexone maintenance for heroin dependence
Sullivan, M. A., Garawi, F., Bisaga, A. M., Comer, S. D., Carpenter, K. M., Raby, W. N., Anen, S. J., Brooks, A. C., Jiang, H., Akerele, E., et al. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.06.013 · Cited by 52
Intranasal naloxone for the treatment of suspected heroin overdose
Kerr, D., Dietze, P., & Kelly, A. (2008) · Addiction · doi:10.1111/j.1360-0443.2007.02097.x · Cited by 51
Differential involvement of endogenous opioids in sucrose consumption and food reinforcement
HAYWARD, M., SCHAICHBORG, A., Pintar, J. E., & Low, M. J. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.10.015 · Cited by 49
Heroin maintenance for chronic heroin dependents
Ferri, M., Davoli, M., & Perucci, C. A. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003410.pub2 · Cited by 49
Experimental Heat Pain for Detecting Pregnancy-Induced Analgesia in Humans
Carvalho, B., Angst, M. S., Fuller, A. J., Lin, E. C., Mathusamy, A. D., & Riley, E. T. (2006) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000239224.48719.28 · Cited by 46
Karam, E. G., Yabroudi, P., & Melhem, N. (2002) · Comprehensive Psychiatry · doi:10.1053/comp.2002.35910 · Cited by 46
Haro, G., Mateu, C., Martı́nez-Raga, J., Valderrama, J. C., Castellano, M., & Cervera, G. (2004) · European Psychiatry · doi:10.1016/j.eurpsy.2004.04.004 · Cited by 39
Long-Run Abstinence After Narcotics Abuse: What Are the Odds?
Dekimpe, M. G., Gucht, L. M. V. D., Hanssens, D. M., & Powers, K. I. (1998) · Management Science · doi:10.1287/mnsc.44.11.1478 · Cited by 38
The Treatment of Opioid Dependence
(2007) · American Journal on Addictions · doi:10.1080/10550490701375228 · Cited by 37
A randomised, controlled trial of low dose naltrexone for the treatment of opioid dependence
Rea, F., Bell, J. R., Young, M. R., & Mattick, R. P. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.02.003 · Cited by 34
Sigmon, S., Dunn, K., Badger, G., Heil, S., & Higgins, S. (2008) · Addictive Behaviours · doi:10.1016/j.addbeh.2008.11.017 · Cited by 30
Anglin, M. D., Conner, B. T., Annon, J., & Longshore, D. L. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.01935.x · Cited by 25
Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal
Gowing, L., Ali, R. L., & White, J. M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002022.pub2 · Cited by 24
DSM-III Personality Type and Dose Levels in Methadone Maintenance Patients
Treece, C., & Nicholson, B. L. (1980) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198010000-00006 · Cited by 23
Methadone Doses and Psychopathological Symptoms During Methadone Maintenance
Maremmani, I., Zolesi, O., Agueci, T., & Castrogiovanni, P. (1993) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1993.10472277 · Cited by 21
Ponizovsky, A. M., Grinshpoon, A., Margolis, A., Cohen, R., & Rosca, P. (2006) · Addictive Behaviors · doi:10.1016/j.addbeh.2006.01.014 · Cited by 21
Opioid antagonists with minimal sedation for opioid withdrawal
Gowing, L., Ali, R. L., & White, J. M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002021.pub2 · Cited by 19
Drug addiction research: moving toward the 21st century
Leshner, A. I. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00061-1 · Cited by 18
Recent advances in the treatment of opiate addiction
Ling, W. W., & Compton, P. A. (2005) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2005.08.012 · Cited by 18
A randomized control trial of group counseling in a naltrexone treatment program
Tucker, T., Ritter, A. J., Maher, C., & Jackson, H. J. (2004) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2004.08.003 · Cited by 17
Research Report Series: Prescription Drugs: Abuse and Addiction
(2005) · PsycEXTRA Dataset · doi:10.1037/e587042011-001 · Cited by 17
Antisocial Personality Disorder and Opioid Treatment Outcomes: A Review
Havens, J. R., & Strathdee, S. A. (2005) · Addictive Disorders & Their Treatment · doi:10.1097/01.adt.0000155725.14375.6e · Cited by 14
Pharmacologie de la buprénorphine
Arnould, J. F., & PINAUD, M. (1991) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/s0750-7658(05)80295-3 · Cited by 13
Longitudinal Effects of LAAM and Methadone Maintenance on Heroin Addict Behavior
Anglin, M. D., Conner, B. T., Annon, J. J., & Longshore, D. L. (2008) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-008-9155-x · Cited by 7
Medication-Free Treatment of Opioid Dependence
Leon, G. D., Jones, H. E., & Stitzer, M. L. (2006) · Cited by 2
Mistral, W., Wilkinson, S., Mastache, C., Midgley, S., & Law, F. D. (2008) · Drugs Education Prevention and Policy · doi:10.1080/09687630601109098 · Cited by 1
Research works printed but not linked: 2
- Johnston, 2008, Monitoring the future national survey results on drug use, 1975–2007, Vol. 1.
- Maremmani, 2003, Dual diagnosis heroin addicts. The clinical and therapeutic aspects, Heroin Addiction and Related Clinical Problems, 5, 7
Cited by
Sorted by citations
Medication-Assisted Treatment of Opioid Use Disorder
Connery, H. S. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000075 · Cited by 577
Stigma at every turn: Health services experiences among people who inject drugs
Paquette, C. E., Syvertsen, J. L., & Pollini, R. A. (2018) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2018.04.004 · Cited by 504
Treatment of substance abusing patients with comorbid psychiatric disorders
Kelly, T. M., Daley, D. C., & Douaihy, A. B. (2011) · Addictive Behaviors · doi:10.1016/j.addbeh.2011.09.010 · Cited by 306
Prescription Opioid Misuse, Abuse, and Treatment in the United States: An Update
Brady, K. T., McCauley, J. L., & Back, S. E. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15020262 · Cited by 249
Bonhomme, J. J. E., Shim, R. S., Gooden, R., Tysu, D., & Rust, G. S. (2012) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)30175-9 · Cited by 233
Metadata
- Authors
- Veilleux, J. C., Colvin, P. J., Anderson, J., York, C., & Heinz, A. J.
- Affiliations
- University of Illinois Chicago (US)
- Corresponding author
- Veilleux, Jennifer C.
- Venue
- Clinical Psychology Review
- Publisher
- Elsevier BV
- Published
- 2010-03
- Volume
- 30
- Issue
- 2
- Pages
- 155-166
- ISSN
- 0272-7358 (ISSN-L)
- OpenAlex
- W2038833041
- Cited by
- 336
- References
- 130
- Citations by year
- 2026: 2 · 2025: 12 · 2024: 11 · 2023: 13 · 2022: 21 · 2021: 12 · 2020: 24 · 2019: 62 · 2018: 24 · 2017: 22 · 2016: 18 · 2015: 24 · 2014: 29 · 2013: 22 · 2012: 20
- FWCI
- 1.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Psychology Review (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- opioid use disorder, opioid dependence treatment, pharmacological interventions, psychosocial interventions, methadone, buprenorphine, LAAM, naltrexone, alpha-2 adrenergic agonists, opioid agonists, opioid antagonists, opioid detoxification, abstinence-based treatment, maintenance therapy, opioid overdose prevention, comorbidities, prescription opioid abuse
- MeSH terms
- Biofeedback, Psychology, Humans, Narcotic Antagonists, Opioid-Related Disorders, Narcotics, Self-Help Groups, Cognitive Behavioral Therapy, Prevalence, Adrenergic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review